A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes

Obesity

Volumn 17, Issue 2, 2009, Pages 310-317

  Nagao, Tomonori ^a   Meguro, Shinichi ^a   Hase, Tadashi ^a   Otsuka, Kazuhiro ^a   Komikado, Masanori ^a   Tokimitsu, Ichiro ^a   Yamamoto, Takashi ^b   Yamamoto, Kunio ^b  

^a KAO CORPORATION   (Japan)

^b KOSHIEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; CATECHIN; GLYCOSYLATED HEMOGLOBIN;

ADIPOSE TISSUE; AGED; ARTICLE; BEVERAGE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADIPONECTIN; ADIPOSE TISSUE; AGED; BEVERAGES; BLOOD GLUCOSE; BLOOD PRESSURE; CATECHIN; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY;

EID: 58849096189     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.505     Document Type: Article

References (24)

1. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-350.
2. Yoshino K, Hara Y, Sano M, Tomita I. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol Pharm Bull 1994;17:146-149.
3. Chan PT, Fong WP, Cheung YL et al. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 1999;129:1094-1101.
4. Abe I, Seki T, Umehara K et al. Green tea polyphenols: novel and potent inhibitors of squalene epoxidase. Biochem Biophys Res Commun 2000;268:767-771.
5. Ajay M, Gilani AH, Mustafa MR. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci 2003;74:603-612.
6. Dulloo AG, Seydoux J, Girardier L, Chantre P, Vandermander J. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes 2000;24:252-258.
7. Dulloo AG, Duret C, Rohrer DI et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999;70:1040-1045.
8. Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 2002;26:1459-1464.
9. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 2007;15: 1473-1483.
10. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A; JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006;144:554-562.
11. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) 2005;51:335-342.
12. Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y. Reduction of blood glucose levels by tea catechin. Biosci Biotech Biochem 1993;57:525-527.
13. Strobel P, Allard C, Perez-Acle T et al. Myricetin, quercetin and catechingallate inhibit glucose uptake in isolated rat adipocytes. Biochem J 2005;386:471-478.
14. Wolfram S, Raederstorff D, Preller M et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 2006;136:2512-2518.
15. Han MK. Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp Mol Med 2003;35: 136-139.
16. The National Nutrition Survey in Japan, 2004. Dai-ichi Shuppan: Tokyo, Japan, 2006.
17. Hosokawa K, Matsuoka K. Staged diabetes management manual (Japanese version 2001). Nippon Rinsho 2002;60:167-173.
18. Examination Committee of Criteria for "Obesity Disease" in Japan; Japan Society for the Study of Obesity. New criteria for "obesity disease" in Japan. Circ J 2002;66:987-992.
19. Kurioka S, Murakami Y, Nishiki M et al. Relationship between visceral fat accumulation and anti-lipolytic action of insulin in patients with type 2 diabetes mellitus. Endocr J 2002;49:459-464.
20. Ryo M, Nakamura T, Kihara S et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004;68:975-981.
21. T, Kim SY, Pérusse L, Després JP, Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord 1999;23:801-809.
22. Kitabchi AE, Umpierrez GE, Murphy MB et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001;24:131-153.
23. Duffy SJ, Keaney JF Jr, Holbrook M et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001;104:151-156.
24. Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 1986;32:613-622.